Indices

Group 1, n = 63

Group 2, n = 121

Group 3, n = 99

Follow-up period

2 yrs.

2 yrs.

4 yrs.

Management approach

Surgical

Sparing

Sparing

Operated, including stent-graft implantation

56 (88.9%)

17 (14.0%)

24 (24.2%)

6

8

8

Non-operated, including due to severity of

7 (11.1%)

104(86.0%)

75 (75.8%)

the disease

7 (11.1%)

29 (24.0%)

22 (22.2%)

Mortality rate among operated pts.,

8(14.3%)

1 (0.83%)

5 (20.8%)

including that not associated with the operation

4 (7.14%)

-

3 (12.5%)

Mortality rates among non-operated pts.

5 (71.4%)

11 (10.6%)

18 (24%)

Mortality rate due to aneurysm rupture,

4 (6.35%)

4 (3.3%)

8 (8.1%)

- Among operated pts. on aorta

2 (3.57%)

-

2 (8.3%)

- Among non-operated pts.

2 (28.6%)

4 (3.85%)

6 (8%)

Mortality rate due to other diseases,

7 (11.1%)

7 (5.8%)

13 (13.1%)

- Among operated pts. on aorta

4 (7.14%)

-

1 (4.2%)

- Among non-operated pts.

3 (42.86%)

7 (6.7%)

12 (16%)

All-cause mortality

13 (20.6%)

12 (9.92%)

23 (23.2%)